| Precise and efficient siRNA design: a key point in competent gene silencing E Fakhr, F Zare, L Teimoori-Toolabi Cancer gene therapy 23 (4), 73-82, 2016 | 183 | 2016 |
| MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines M Azizi, L Teimoori-Toolabi, MK Arzanani, K Azadmanesh, ... Cancer biology & therapy 15 (4), 419-427, 2014 | 92 | 2014 |
| MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition A Afgar, P Fard-Esfahani, A Mehrtash, K Azadmanesh, F Khodarahmi, ... Cancer biology & therapy 17 (11), 1126-1138, 2016 | 50 | 2016 |
| Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p M Ghanbarian, A Afgar, R Yadegarazari, R Najafi, L Teimoori-Toolabi Biomedicine & pharmacotherapy 108, 1070-1080, 2018 | 41 | 2018 |
| Molecular alterations contributing to pancreatic cancer chemoresistance A Rajabpour, F Rajaei, L Teimoori-Toolabi Pancreatology 17 (2), 310-320, 2017 | 41 | 2017 |
| Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer F Khatami, B Larijani, R Heshmat, A Keshtkar, M Mohammadamoli, ... PloS one 12 (9), e0184892, 2017 | 40 | 2017 |
| Downregulation of miR‑1266‑5P, miR‑185‑5P and miR‑30c‑2 in prostatic cancer tissue and cell lines S Ostadrahimi, S Fayaz, M Parvizhamidi, M Abedi‑Valugerdi, M Hassan, ... Oncology letters 15 (5), 8157-8164, 2018 | 34 | 2018 |
| MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells A Rajabpour, A Afgar, H Mahmoodzadeh, JD Radfar, F Rajaei, ... Cancer chemotherapy and pharmacology 80, 765-775, 2017 | 34 | 2017 |
| RNA-Mediated Gene Silencing in Candida albicans: Inhibition of Hyphae Formation by Use of RNAi Technology M Moazeni, MR Khoramizadeh, P Kordbacheh, Z Sepehrizadeh, ... Mycopathologia 174, 177-185, 2012 | 34 | 2012 |
| Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors R Jahangiri, F Mosaffa, A Emami Razavi, L Teimoori‐Toolabi, ... Journal of cellular physiology 233 (9), 7305-7319, 2018 | 33 | 2018 |
| Detection of aberrant methylated SEPT9 and NTRK3 genes in sporadic colorectal cancer patients as a potential diagnostic biomarker S Behrouz Sharif, S Hashemzadeh, R Mousavi Ardehaie, A Eftekharsadat, ... Oncology letters 12 (6), 5335-5343, 2016 | 33 | 2016 |
| Apolipoprotein E genotype and age at menopause J Koochmeshgi, S MEHDI HOSSEINI‐MAZINANI, S MORTEZA SEIFATI, ... Annals of the New York Academy of Sciences 1019 (1), 564-567, 2004 | 32 | 2004 |
| MiR-377 reverses cancerous phenotypes of pancreatic cells via suppressing DNMT1 and demethylating tumor suppressor genes M Azizi, P Fard-Esfahani, H Mahmoodzadeh, MS Fazeli, K Azadmanesh, ... Epigenomics 9 (8), 1059-1075, 2017 | 31 | 2017 |
| Hypermethylated RASSF1 and SLC5A8 promoters alongside BRAFV600E mutation as biomarkers for papillary thyroid carcinoma F Khatami, B Larijani, R Heshmat, S Nasiri, M Haddadi‐Aghdam, ... Journal of cellular physiology 235 (10), 6954-6968, 2020 | 26 | 2020 |
| Selective suicide gene therapy of colon cancer exploiting the urokinase plasminogen activator receptor promoter L Teimoori-Toolabi, K Azadmanesh, A Amanzadeh, S Zeinali BioDrugs 24, 131-146, 2010 | 26 | 2010 |
| Autophagy induction reduces telomerase activity in HeLa cells F Taji, HM Kouchesfahani, F Sheikholeslami, B Romani, K Baesi, ... Mechanisms of ageing and development 163, 40-45, 2017 | 25 | 2017 |
| Evaluation of an albumin-binding domain protein fused to recombinant human IL-2 and its effects on the bioactivity and serum half-life of the cytokine E Adabi, F Saebi, AM Hasan-Abad, L Teimoori-Toolabi, GA Kardar Iranian biomedical journal 21 (2), 77, 2017 | 24 | 2017 |
| Selective suicide gene therapy of colon cancer cell lines exploiting fibroblast growth factor 18 promoter L Teimoori-Toolabi, K Azadmanesh, S Zeinali Cancer Biotherapy and Radiopharmaceuticals 25 (1), 105-116, 2010 | 22 | 2010 |
| Aberrant methylated EDNRB can act as a potential diagnostic biomarker in sporadic colorectal cancer while KISS1 is controversial R Mousavi Ardehaie, S Hashemzadeh, S Behrouz Sharif, M Ghojazadeh, ... Bioengineered 8 (5), 555-564, 2017 | 21 | 2017 |
| cyp51A gene silencing using RNA interference in azole‐resistant Aspergillus fumigatus B Mousavi, MT Hedayati, L Teimoori‐Toolabi, J Guillot, A Alizadeh, ... Mycoses 58 (12), 699-706, 2015 | 21 | 2015 |
